Pathogenic role of glial cells in Parkinson's disease

被引:220
作者
Teismann, P
Tieu, K
Cohen, O
Choi, DK
Wu, DC
Marks, D
Vila, M
Jackson-Lewis, V
Przedborski, S
机构
[1] Columbia Univ, Dept Neurol, Movement Disorder Div, New York, NY 10032 USA
[2] Mamaroneck High Sch, Mamaroneck, NY USA
[3] Columbia Univ, Dept Pathol, New York, NY 10032 USA
关键词
astrocyte; gliosis; IL-1; beta; iNOS; microglia; MPTP; neurodegeneration; Parkinson's disease;
D O I
10.1002/mds.10332
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Parkinson's disease (PD) is a common neurodegenerative disorder characterized by the progressive loss of the dopaminergic neurons in the substantia nigra pars compacta (SNpc). The loss of these neurons is associated with a glial response composed mainly of activated microglial cells and, to a lesser extent, of reactive astrocytes. This glial response may be the source of trophic factors and can protect against reactive oxygen species and glutamate. Alternatively, this glial response can also mediate a variety of deleterious events related to the production of pro-oxidant reactive species, and pro-inflammatory prostaglandin and cytokines. We discuss the potential protective and deleterious effects of glial cells in the SNpc of PD and examine how those factors may contribute to the pathogenesis of this disease. (C) 2002 Movement Disorder Society.
引用
收藏
页码:121 / 129
页数:9
相关论文
共 96 条
[1]  
ADAMS RD, 1986, HDB CLIN NEUROLOGY E, P205
[2]   MICROGLIAL RESPONSE TO 6-HYDROXYDOPAMINE-INDUCED SUBSTANTIA NIGRA LESIONS [J].
AKIYAMA, H ;
MCGEER, PL .
BRAIN RESEARCH, 1989, 489 (02) :247-253
[3]   Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) [J].
Ara, J ;
Przedborski, S ;
Naini, AB ;
Jackson-Lewis, V ;
Trifiletti, RR ;
Horwitz, J ;
Ischiropoulos, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (13) :7659-7663
[4]   Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease [J].
Banati, RB ;
Daniel, SE ;
Blunt, SB .
MOVEMENT DISORDERS, 1998, 13 (02) :221-227
[5]   CYTOTOXICITY OF MICROGLIA [J].
BANATI, RB ;
GEHRMANN, J ;
SCHUBERT, P ;
KREUTZBERG, GW .
GLIA, 1993, 7 (01) :111-118
[6]   Inhibition of brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor expression reduces dopaminergic sprouting in the injured striatum [J].
Batchelor, PE ;
Liberatore, GT ;
Porritt, MJ ;
Donnan, GA ;
Howells, DW .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2000, 12 (10) :3462-3468
[7]  
Batchelor PE, 1999, J NEUROSCI, V19, P1708
[8]   Experimental models of Parkinson's disease [J].
Beal, MF .
NATURE REVIEWS NEUROSCIENCE, 2001, 2 (05) :325-332
[9]   Implication of the subthalamic nucleus in the pathophysiology and pathogenesis of Parkinson's disease [J].
Benazzouz, A ;
Piallat, B ;
Ni, ZG ;
Koudsie, A ;
Pollak, P ;
Benabid, AL .
CELL TRANSPLANTATION, 2000, 9 (02) :215-221
[10]   IL-1β, IL-2, IL-6 and TNF-α production by peripheral blood mononuclear cells from patients with Parkinson's disease [J].
Bessler, H ;
Djaldetti, R ;
Salman, H ;
Bergman, M ;
Djaldetti, M .
BIOMEDICINE & PHARMACOTHERAPY, 1999, 53 (03) :141-145